The investigators reported that treatment with darolutamide reduced the risk of radiological progression or death by 49% in ...

Video content above is prompted by the following: Aqua Ablation Therapy Benefits Efficacy: Aqua ablation demonstrates noninferior, equal, or superior results compared with TURP (gold standard).

Welcome back to Pearls & Perspectives, with Amy Pearlman, MD! In this episode of Pearls and Perspectives, host Amy Pearlman, MD sits down with Andrew Y. Sun, MD, during the American Urological ...

Joseph Jacob, MD, outlines key findings on TAR-200 monotherapy from cohort 2 of the SunRISe-1 study. “If you look at the data, it's phenomenal data. It's the highest [complete response] CR rate ...

"The decision for which laser to use in your institution should be left up to the urologist and the hospital system," says Margaret A. Knoedler, MD. Data presented at the 2025 American Urological ...

In an interview with Urology Times®, John L. Gore, MD, MS, FACS, shares the background and key findings from the study, “Radical Cystectomy Versus Bladder-Sparing Therapy For Recurrent High-Grade ...

Sasanlimab plus BCG significantly improved EFS compared to BCG alone in high-risk NMIBC patients, with a 32% lower risk of EFS events. The study involved 1055 BCG-naïve patients, focusing on EFS, ...

In an interview with Urology Times®, Jason M. Hafron, MD, CMO, discusses his talk, “Barriers in Recruiting and Running Effective Clinical Trials in Independent Practices,” which was presented at the ...

Higher levels of drinking water contaminants are associated with increased kidney stone burden and recurrence, independent of socioeconomic factors. The study analyzed over 1100 California residents, ...

ADAM, a hydrogel-based male contraceptive, blocks sperm transport without affecting sensation or ejaculation, showing promise in early trials. The 90-day safety analysis reported no procedural adverse ...

Social media platforms are major sources of prostate cancer misinformation, affecting patient education and care provider relationships. Misinformation is often spread by unlicensed individuals posing ...

TARA-002 demonstrated a 100% high-grade complete response in BCG-unresponsive patients at 6 months, with a 76% CR in BCG-naïve patients. The agent acts as a broad-spectrum immune potentiator, ...